Andrew J Murphy
Disclosed holdings of Andrew J Murphy as of 2026-10-14: 48K shares of Regeneron Pharmaceuticals (REGN), worth about $37.4M at the last close. In 12 months…
What Andrew J Murphy reported holding
As of the latest filing on , Andrew J Murphy reported holding 47,833 shares of Regeneron Pharmaceuticals (REGN), worth about $37.4M at the last close of $782 (Oct 19, 2026). In the last 12 months, Andrew J Murphy sold $3.2M in 27 sales.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Regeneron Pharmaceuticals REGN | 47,833 | 48K direct | $782 | $37.4M | Oct 14, 2026 |
Is this Andrew J Murphy’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Insider buying and selling since 2020
Andrew J Murphy has no open-market purchase on record since 2020. Sales in 6 of the 7 years since 2020.
Andrew J Murphy reported 0 open-market purchases and 236 sales since 2020; no open-market purchase.
| Year | Bought | Sold |
|---|---|---|
| 2026 | — | 27×27 trades |
| 2024 | — | 32×32 trades |
| 2023 | — | 23×23 trades |
| 2022 | — | 57×57 trades |
| 2021 | — | 33×33 trades |
| 2020 | — | 64×64 trades |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. The amounts, the people and every filing are in OQRO Pro.
The company behind these filings
- Regeneron Pharmaceuticals REGN
Andrew J Murphy reported 0 open-market purchases and 236 sales here, 2020 to 2026.
- Market value
- $80.5B
- Last close
- $782.04
- 12 months
- +35.3%
- Against the S&P 500
- +19.9 pts
- Net margin
- 31.4%
- Revenue (last year)
- $14.3B
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
Trades disclosed
Latest trade
Largest trade
Companies
Every disclosed trade
Every trade this person has disclosed
Newest first, each one linked to the filing it came from.
Free account: get the written context of this page. Already a member? Sign in
What this page holds
- Every disclosed trade, newest first
- How purchases did after they were reported
- Companies and committees involved
- A link to every official filing
What OQRO is
OQRO reads the public record for US-listed companies — insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings, and federal contract awards — and puts each one in plain words next to the filing it came from. It describes what was disclosed. It does not give investment advice or tell you what to buy.
Want to see real filings before you pay? The home page shows live ones, free, with the link to each source document.
Questions about Andrew J Murphy's trades
Has Andrew J Murphy bought shares on the open market?
Andrew J Murphy has no open-market purchase on record since 2020. Sales in 6 of the 7 years since 2020.
When did Andrew J Murphy last buy or sell shares?
In SEC filings since 2020: no open-market purchase is on record; the latest open-market sale is from 2026.
Which companies has Andrew J Murphy traded as an insider?
Regeneron Pharmaceuticals (REGN), from 2020 to 2026: 0 purchases and 236 sales.